| General Information of Drug Metabolite (DM) (ID: DM017576) |
| DM Name |
Almogran metabolite M5
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Dimethylaniline oxidase 3 (FMO3)
|
DME0039
|
| Oxidation - N-oxidation |
Almogran
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Almogran |
DR5185
|
Approved |
Migraine |
|
|
| References |
| 1 |
Almotriptan, a new anti-migraine agent: a review. CNS Drug Rev. 2002 Fall;8(3):217-34.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
